Across TCGA pan-cancer cohorts, HSFY3P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated HSFY3P data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher HSFY3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HSFY3P expression acts as an unfavorable survival marker, although some lineages such as UVM and THYM show a favorable association.
STAD, THCA, and UVM are the cancer types where HSFY3P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.